Randomized clinical trial of an implantable drug delivery system compared with comprehensive medical management for refractory cancer pain: impact on pain, drug-related toxicity, and survival. Data is temporarily unavailable. This is a sponsored profile. Dr. Innocent Njoku MD is a male resident in Albany, NY. Innocent Chibu Njoku, age 49, Colonial Heights, VA 23834 View Full Report. There are 10+ professionals named "Innocent Njoku", who use LinkedIn to exchange information, ideas, and opportunities. Age, preoperative pain scores, and individual change in pain scores showed normal distribution using the Shapiro-Wilk test (with We chose as the dependent variable postoperative intrathecal dose (in IV morphine equivalents). 30 mins. directories, and profiles on CareDash, please visit our Insurance Accepted. Potential overdosing is mitigated by the opioid tolerance many of these patients exhibit. Innocent Njoku has published 2 articles and reviewed 0 in The Cureus Journal of Medical Science. Another 16 patients had intrathecal pumps without an epidural trial and were excluded because of inadequate prepump data. The 1033572300 NPI number is assigned to the healthcare provider “INNOCENT NJOKU M.D.”, practice location address at “47 NEW SCOTLAND AVE DEPT OF ALBANY, NY, 12208-3412”. Only 2 patients admitted for epidural trials failed; however, both had no diagnosis of cancer and since neither had an implant, they were not part of the 46 patients based on CPT coding.For the 46 patients in the final pool, age, gender, cancer type, and date of admission for the trial were noted. 1997;20:88–936. Known Locations: Bronx NY … directories, and profiles on CareDash, please visit our Please try after some time.Get new journal Tables of Contents sent right to your email inbox Your Email:
For more information, please refer to our Privacy Policy. Building personal, lasting, one-on-one relationships with patients. Although we performed mainly descriptive statistics (median, IQR), we found no 1 cancer type to be overrepresented for intrathecal pump placement or any patient to have purely neuropathic pain (e.g., chemotherapy-induced neuropathy). Third-party partners that represent the provider to CareDash 2015 Mar 07Alimi, M.,Njoku, I.,Cong, G. T.,Pyo, S. Y.,Hofstetter, C. P.,Grunert, P.,Härtl, R.> ;Neurosurgery. Smith TJ, Staats PS, Deer T, Stearns LJ, Rauck RL, Boortz-Marx RL, Buchser E, Catala E, Bryce DA, Coyne PJ, Pool GE.
Length of stay (LOS) was defined as date of placement of epidural trial catheter (taken to represent the start of the trial and achievement of best systemic analgesia) until date of discharge postpump implant.Additional measures analyzed included change in pain score per patient (from pre-epidural trial until discharge after intrathecal pump placement) and time until death (if applicable) from placement of intrathecal pump.Descriptive statistics for quantitative variables that were normally distributed include mean and SD. 301-223-2300 Please try after some time.Your message has been successfully sent to your colleague.Some error has occurred while processing your request. 1985;313:84–95 Clinical realities and economic considerations: economics of intrathecal therapy. Attestation: Kenneth Cubert approved the final manuscript. Get matched with a doctor like Seth who gives you time and attention you deserve. If you'd like to highlight your profile at the top of relevant searches,
Copyright 2020 innocent njoku, md